Tarsus Pharmaceuticals (TARS) Asset Utilization Ratio (2021 - 2026)

Tarsus Pharmaceuticals' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.94 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 75.8% year-over-year to 0.94; the TTM figure through Mar 2026 stood at 0.94 (up 75.8% YoY), while the FY2025 annual figure was 0.96, up 68.78% from the prior year.
• Asset Utilization Ratio was 0.94 for Q1 2026 at Tarsus Pharmaceuticals, up from 0.82 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.94 in Q1 2026 to a low of 0.06 in Q2 2023.
• Historically, Asset Utilization Ratio has averaged 0.32 across 5 years, with a median of 0.14 in 2024.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio sank 77.06% in 2022, then surged 643.11% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.11 in 2022, then tumbled by 41.22% to 0.07 in 2023, then soared by 643.11% to 0.49 in 2024, then soared by 69.45% to 0.82 in 2025, then increased by 13.72% to 0.94 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.94 (Q1 2026), 0.82 (Q4 2025), and 0.71 (Q3 2025), per Business Quant data.